TREE NEWS update: China’s National Health Commission completed registration on Nov. 5 for a clinical study titled “Safety and Feasibility of SCS Combined Non-Invasive Brain-Controlled Hybrid Exoskeleton Training for Lower Limb Motor Impairment in Chronic Stroke.” It is the first non-invasive brain-computer interface clinical research project registered nationwide since the Biomedical New Technology Clinical Research and Translation Application Management Regulations took effect in May 2026, moving the technology into standardized clinical research.
China Registers First Non-Invasive Brain-Computer Interface Clinical Study
AI take
The significance here is regulatory rather than technical: a national registration pathway now exists for non-invasive brain-computer interfaces, which gives such studies a defined compliance route that previously did not exist. That matters most for device developers and clinical researchers, who gain a template for structuring trials, and for hospitals positioning themselves in neurorehabilitation. The open question is whether this first registration becomes a repeatable pattern across other indications and institutions, or remains a one-off.
Generated by AI for reference only.
Share on WeChat
Open WeChat → Scan → then tap "…" to send to a chat or Moments.
Tap "…" in the top-right corner to send to a chat or share to Moments.
Related News
49m ago
EU Commission unveils education and skills package
50m ago
ING Seeks Bids on $500M Data Center Loan Portfolio
1h ago
China’s Six Departments Push Embodied AI, LLMs, BCIs Into Elderly Care
1h ago
China A-share computing power leasing stocks jump; Runjian shares hit limit up
3h ago
Chinese Models Capture 89% of US Enterprise Open-Source AI Spending: Menlo Ventures
3h ago
Zhongji Innolight says orders cover all of 2027, prepares capacity